Comparative study of X-ray treatment and photodynamic therapy by using 5-aminolevulinic acid conjugated gold nanoparticles in a melanoma cell line

References

• Alkilany AM, Murphy CJ. 2010. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res. 12:2313–2333.
   PubMed Web of Science ®Google Scholar
• Becker ML, Bailey LO, Wooley KL. 2004. Peptide‐derivatized shell‐cross‐linked nanoparticles. 2. Biocompatibility evaluation. Bioconjug Chem. 1:710–717.
   Google Scholar
• Butterworth KT, Coulter JA, Jain S, Forker J, McMahon SJ, Schettino G, et al. 2010. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology. 21:1–18.
   Web of Science ®Google Scholar
• Cabuy E. 2012. Reliable cancer therapies. Energy-based Therap. 3:1–54.
   Google Scholar
• Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 1:325–327.
   PubMed Web of Science ®Google Scholar
• Goodman CM, McCusker CD, Yilmaz T, Rotello VM. 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem. 15:897–900.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. 2004. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 49:N309–N315.
   PubMed Web of Science ®Google Scholar
• Hauck TS, Ghazani AA, Chan WC. 2008. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small. 4:153–159.
   PubMed Web of Science ®Google Scholar
• Kim CH, Chung CW, Choi KH, Yoo JJ, Kim do H, Jeong YI, Kang DH. 2011. Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells. Int J Nanomedicine. 6:1357–1363.
   PubMed Web of Science ®Google Scholar
• Lkhagvadulam B, Kim JH, Yoon I, Shim YK. 2013. Size-dependent photodynamic activity of gold nanoparticles conjugate of water soluble purpurin-18-N-methyl-d-glucamine. Biomed Res Int. 2013:720579.
   PubMed Web of Science ®Google Scholar
• Luksiene Z, Juzenas P, Moan J. 2006. Radiosensitization of tumours by porphyrins. Cancer Lett. 235:40–47.
   PubMed Web of Science ®Google Scholar
• Mironava T, Hadjiargyrou M, Simon M, Rafailovich MH. 2014. Gold nanoparticles cellular toxicity and recovery: adipose derived stromal cells. Nanotoxicology. 8:189–201.
   PubMed Web of Science ®Google Scholar
• Mironava T, Hadjiargyrou M, Simon M, Jurukovski V, Rafailovich MH. 2010. Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time. Nanotoxicology. 4:120–137.
   PubMed Web of Science ®Google Scholar
• Mohammadi Z, Sazgarnia A, Rajabi O, Soudmand S, Esmaily H, Sadeghi HR. 2013. An in vitro study on the photosensitivity of 5-aminolevulinic acid conjugated gold nanoparticles. Photodiagnosis Photodyn Ther. 10:382–388.
   PubMed Web of Science ®Google Scholar
• Oo MK, Yang X, Du H, Wang H. 2008. 5-Aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine. 3:777–786.
   PubMed Web of Science ®Google Scholar
• Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L. 2004. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11:169–183.
   PubMed Web of Science ®Google Scholar
• Popov AP, Priezzhe AV, Myllylä1 R. 2007. Optimal sizes of gold nanoparticles for laser treatment of tumors. Fifth International Conference on Photonics and Imaging in Biology and Medicine. Proceedings of SPIE; Wuhan, China.
   Google Scholar
• Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C, Davidson R, Geso M. 2009. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine. 5:136–142.
   PubMed Web of Science ®Google Scholar
• Sultan SM, El-Doray AA, Hofstetter A, Abdel-Gawad O, El-MahdyAel D, Khoder W. 2006. Photodynamic selectivity of 5-aminolevulinic acid to prostate cancer cells. J Egypt Natl Canc Inst. 18:382–386.
   PubMedGoogle Scholar
• Takahashi J, Misawa M, Murakami M, Mori T, Nomura K, Iwahashi H. 2013. 5-Aminolevulinic acid enhances cancer radiotherapy in a mouse tumor model. Springerplus. 2:602.
   Google Scholar
• Thomas WD, Hersey P. 1998. TNF-related apoptosis-inducing ligand(TRAIL) induces apoptosis in Fas ligand-resistant melanomacells and mediates CD4T cell killing of target cells. J Immunol. 161:2195–2200.
   PubMed Web of Science ®Google Scholar
• Wachowska M, Muchowicz A, Firczuk M, Gabrysiak M, Winiarska M, Wańczyk M, Bojarczuk K, Golab J. 2011. Aminolevulinic Acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules. 16:4140–4164.
   Web of Science ®Google Scholar
• Wieder ME, Hone DC, Cook MJ, Handsley MM, Gavrilovic J, Russell DA. 2006. Intracellular photodynamic therapy with photo sensitizer—nanoparticles conjugates: cancer therapy using a Trojan horse. Photochem Photobiol Sci. 5:727–734.
   PubMed Web of Science ®Google Scholar
• Xu H, Liu C, Mei J, Yao C, Wang S, Wang J, Li Z, Zhang Z. 2012. Effects of light irradiation upon photodynamic therapy based on 5-aminolevulinic acid-gold nanoparticle conjugates in K562 cells via singlet oxygen generation. Int J Nanomedicine. 7:5029–5038.
   PubMed Web of Science ®Google Scholar
• Yah CS. 2013. The toxicity of gold nanoparticles in relation to their physiochemical properties. Biomed Res. 24:400–413.
   Web of Science ®Google Scholar
• Yamamoto J, Ogura S, Tanaka T, Kitagawa T, Nakano Y, Saito T, et al. 2012. Radiosensitizing effect of 5-aminolevulinic acid-induced protoporphyrin IX in glioma cells in vitro. Oncol Rep. 27:1748–1752.
   PubMed Web of Science ®Google Scholar